Is Procter & Gamble a Bargain After Recent Product Innovation Headlines?

• Curious if Procter & Gamble is a hidden bargain or trading at a premium? You are not alone, as many investors are taking a closer look at its true worth right now.
• After a mixed start to the year, the share price sits at $148.16, slipping 1.5% over the last month and down 10.7% year-to-date. This has set the stage for fresh speculation about its next move.
• Recent headlines have highlighted Procter & Gamble’s latest product innovations and strategic sustainability initiatives, both of which seem to be shaping investor sentiment. These updates have contributed to renewed conversations around the company's long-term growth outlook and ability to adapt in an evolving consumer landscape.
• On our full valuation scorecard, Procter & Gamble receives a 2 out of 6 for undervaluation, so there is still plenty of debate about where fair value really sits. Next, we will break down several valuation approaches, and discuss what may be the most effective way to look at value by the end of this article.

Procter & Gamble scores just 2/6 on our valuation checks. See what other red flags we found in the full valuation breakdown.

Approach 1: Procter & Gamble Discounted Cash Flow (DCF) Analysis

A Discounted Cash Flow (DCF) model estimates a company's intrinsic value by projecting its future cash flows and discounting them back to the present. This process provides an estimate of what the business is worth today, based on expectations for future performance.

For Procter & Gamble, the most recent Free Cash Flow stands at $15.40 billion. Analyst forecasts extend up to five years, and by 2028, projections call for annual Free Cash Flow to reach $16.98 billion. Beyond that period, further growth estimates are extrapolated, with the DCF model projecting around $21.36 billion in Free Cash Flow by 2035. Certainty around these figures decreases the further out they are projected.

After totaling these discounted cash flows using the 2 Stage Free Cash Flow to Equity model, Procter & Gamble's intrinsic value is estimated at $185.05 per share. With the current share price at $148.16, this suggests the stock is trading at a 19.9% discount to its calculated fair value, indicating it is potentially undervalued relative to its fundamentals.

Result: UNDERVALUED

Our Discounted Cash Flow (DCF) analysis suggests Procter & Gamble is undervalued by 19.9%. Track this in your watchlist or portfolio, or discover 915 more undervalued stocks based on cash flows.

Head to the Valuation section of our Company Report for more details on how we arrive at this Fair Value for Procter & Gamble.

Approach 2: Procter & Gamble Price vs Earnings

For established and profitable companies like Procter & Gamble, the Price-to-Earnings (PE) ratio is often the preferred valuation tool. The PE ratio tells investors how much they are paying today for each dollar of the company’s earnings, making it a useful benchmark for companies with stable profits and predictable growth.

What constitutes a "normal" or "fair" PE ratio can depend on several factors, including a company's future earnings growth prospects and its perceived risk. Higher growth or lower risk usually justify a higher PE, while slower growth or higher risk can result in a lower PE.

Procter & Gamble currently trades at a PE of 21.0x. Compared to the broader Household Products industry average of 17.4x and the peer average of 20.9x, Procter & Gamble sits just above its direct competitors and the sector overall. However, benchmarks like peer or industry averages do not always capture the full story when important qualities such as profit margins, growth rates, and company size are considered.

Simply Wall St’s “Fair Ratio” is designed to address these nuances by factoring in Procter & Gamble’s specific growth outlook, risks, margins, and other unique business attributes. This makes it a more rounded estimate of fair value than just comparing against simple averages. For Procter & Gamble, the Fair Ratio is 22.1x.

With the actual PE at 21.0x and the Fair Ratio at 22.1x, Procter & Gamble’s valuation is generally consistent with what is reasonable for its current earnings profile and future prospects.

Result: ABOUT RIGHT

PE ratios tell one story, but what if the real opportunity lies elsewhere? Discover 1441 companies where insiders are betting big on explosive growth.

Upgrade Your Decision Making: Choose your Procter & Gamble Narrative

Earlier, we mentioned an even better way to understand valuation, so let's introduce you to Narratives, a modern approach that connects a company's story with the numbers behind its fair value. A Narrative is simply your perspective on a company’s future, weaving together your expected growth in revenue, earnings, and margins to shape a personal view of what the business is worth. Narratives link this story to concrete financial forecasts and ultimately a fair value estimate for the stock.

On Simply Wall St’s Community page, Narratives make sophisticated investing easy and accessible for everyone. You can compare your fair value estimate with the current share price and see if Procter & Gamble looks attractive right now, helping you decide when to buy or sell. What sets Narratives apart is their dynamic updates. Whenever new data from earnings or breaking news comes through, your Narrative automatically refreshes so your assumptions and valuations stay relevant.

For Procter & Gamble, some investors may craft bullish Narratives based on strong innovation and resilient cash flows, placing fair value as high as $186.00, while others may emphasize slowing growth and assign a more conservative value around $105.00. This demonstrates how powerful and personal this tool can be.

For Procter & Gamble, we will make it easy for you with previews of two leading Procter & Gamble Narratives:

🐂 Procter & Gamble Bull Case

Fair Value: $169.05

Currently 12.4% undervalued compared to this narrative

Revenue Growth Rate: 3.19%

• Investments in innovation and productivity improvements could expand market share and boost net margins, supporting steady earnings growth.
• Analysts expect modest revenue and earnings growth, alongside continued share buybacks and dividend increases, which may drive earnings per share higher.
• Risks include consumer and market volatility, geopolitical pressures, tariffs, and currency fluctuations. The consensus price target sits just 6.7% above the current share price, suggesting analysts view the stock as fairly priced in the near term.

🐻 Procter & Gamble Bear Case

Fair Value: $119.81

Currently 23.7% overvalued compared to this narrative

Revenue Growth Rate: 4.68%

• P&G remains a high-quality, mature business with diversified operations, reliable cash flows, and a decades-long record of dividend growth.
• Revenue and free cash flow growth are expected to moderate, with margins possibly tapering as competitive pressure rises. This may support only modest increases in dividends and earnings over the coming years.
• Valuation methods blending cash flow, dividend expectations, and historical multiples suggest the current share price may be reflecting a premium, leaving limited upside unless growth or margins outperform expectations.

Do you think there's more to the story for Procter & Gamble? Head over to our Community to see what others are saying!

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com